PremiumThe FlyNeuroMetrix trading halted, news pending NeuroMetrix Q3 2024: Mixed Results Amid Strategic Review NeuroMetrix reports Q3 revenue $587,314 vs $1.2M last year PremiumThe FlyNeuroMetrix provides update on review of strategic options NeuroMetrix Board Appointment and Equity Program Termination NeuroMetrix appoints Joshua Horowitz to board, terminates ATM equity facility PremiumThe FlyNeuroMetrix reports Q4 EPS ($1.43) vs (73c) last year NeuroMetrix announces review of strategic options to promote growth NeuroMetrix reports results from pilot trial of Quell in post-acute covid-19